Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Procter & Gamble Company    PG

Mes dernières consult.
Most popular
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

P&G Cuts FY12 EPS View As Sales Slow In Developed Markets

share with twitter share with LinkedIn share with facebook
share via e-mail
04/27/2012 | 05:47pm CEST

--P&G cuts fiscal 2012 view on slowing sales volumes in developed markets

--P&G also cutting price in certain categories

--Shares down 3.3% on lowered view

(Adds details from earnings call.)

    By Paul Ziobro 

Procter & Gamble Co. (>> The Procter & Gamble Company) cut its outlook for the fiscal year on a recent slip in demand in developed markets and the need to backtrack on price increases in a half-dozen business lines, mostly in the U.S.

Price controls in Venezuela, which required price cuts of up to 25% on certain P&G products, also will weigh on results in what is currently a billion-dollar market for the company.

For the year ahead, the company lowered its full-year profit target to $3.82 to $3.88 a share. It had previously forecast earnings of $3.93 to $4.03 a share.

The lowered view, with fiscal 2012 per-share earnings seen flat to down 1%, once again disappointed investors, sending shares down 3.3% in recent trading to $64.69. It came after P&G reported a 16% drop in third-quarter earnings, when the company continued to deal with high commodity costs and took charges related to restructuring plans.

The outlook also raised questions as to whether P&G can capably confront such challenges and fend off competitors while the 175-year-old company undergoes a $10 billion restructuring program over the next four years. P&G executives said the company will continue to add new products, especially in struggling areas like the U.S. and its beauty care business, so sales don't suffer as P&G cuts costs.

"I personally don't think this restructuring program will get in the way of doing that," P&G Chief Executive Bob McDonald said Friday on an earnings call. "If anything, I think it will enable it."

P&G's is lowering prices and increasing promotions in categories where competitors like toothpaste-maker Colgate-Palmolive Co. (>> Colgate-Palmolive Company), Schick razor-owner Energizer Holdings Inc. (ENR) and laundry competitors Unilever PLC (UL, ULVR.LN) and Church & Dwight Co. (>> Church & Dwight Co., Inc.) have dug in on their prices or promoted aggressively.

P&G is giving back $200 million of the $3.5 billion in price increases it has taken this year, a small piece of the pie. But the swift reversals show P&G moved too high in some areas, misjudging consumer and competitor response to its price increases and jeopardizing market share in some key categories.

"We had to put in place some remedial activity to regain the consumer value equation," McDonald said.

P&G executives said that the company is lowering prices in the powdered laundry business in the U.S.; oral care, automatic dishwashing detergent, and blades and razors in North America; and laundry divisions in the U.K. and Mexico.

The weak performance in those areas made P&G lose share in a majority of its markets. The company said it held or increased share in 45% of the categories and countries in which it competes; the figure would have been 55% if it just held share in the categories where the prices are being lowered.

For the quarter ended March 31, P&G reported a profit of $2.41 billion, or 82 cents a share, compared with a year-earlier profit of $2.87 billion, or 96 cents a share. Stripping out items like restructuring costs, P&G reported core earnings of 94 cents a share.

Net sales inched up 1.5% to $20.19 billion. Sales rose 3% on an organic basis, which excludes currency translation, acquisitions and divestitures. The company had forecast earnings of 89 cents to 95 cents a share on flat to 2% net sales growth.

For the year ahead, the company also lowered its full-year profit target, calling for earnings of $3.82 to $3.88 a share. It had previously forecast earnings of $3.93 to $4.03 a share.

-By Paul Ziobro, Dow Jones Newswires; 212-416-2194; [email protected]

Stocks mentioned in the article
ChangeLast1st jan.
CHURCH & DWIGHT CO -0.94% 45.41 Delayed Quote.-8.63%
COLGATE-PALMOLIVE COMPANY -1.70% 66.37 Delayed Quote.-12.03%
PROCTER & GAMBLE COMPANY -1.08% 73 Delayed Quote.-20.55%
UNILEVER -0.17% 3866 Delayed Quote.-6.29%
UNILEVER (NL) -0.29% 45.125 Delayed Quote.-3.62%
share with twitter share with LinkedIn share with facebook
share via e-mail
04/23PROCTER & GAMBLE : Always® #LikeAGirl and Walmart Team up to Support Girl Scouts..
04/23PROCTER & GAMBLE : P&G Announces Third Quarter Earnings; Net Sales +4%; Organic ..
04/23P&G Acquires the Consumer Health Business of Merck KGaA, Darmstadt, Germany
04/22PROCTER & GAMBLE : Brings Relief to Residents Affected by Recent Tornado with P&..
04/21PROCTER & GAMBLE : & Gamble pays $4.2 bln for unit of Germany`s Merck
04/21PROCTER & GAMBLE : P&G Acquires the Consumer Health Business of Merck KGaA, Darm..
04/21PROCTER & GAMBLE : Cedar Rapids, Coralville, Iowa City hope new incentive foster..
04/20P&G's vitamin boost could signal more to come
04/20WRIGHT STATE UNIVERSITY : More Than Skin Deep
04/20P&G to buy majority stake in Merck India business for Rs1,300 crore
More news
News from SeekingAlpha
04/23DIVIDEND SENSEI'S PORTFOLIO UPDATE 3 : 3 Billionaire Habits That Can Make You Ri.. 
04/23PROCTER & GAMBLE : Tough Times Ahead 
04/23RETIREMENT STRATEGY : Waiting For Some Good Buys? Here Are A Few 
04/23CONSUMER STAPLES : It's Time To Buy 
04/22The Schizophrenic Market 
Financials ($)
Sales 2018 66 982 M
EBIT 2018 14 581 M
Net income 2018 10 510 M
Debt 2018 28 028 M
Yield 2018 3,86%
P/E ratio 2018 18,78
P/E ratio 2019 16,37
EV / Sales 2018 3,20x
EV / Sales 2019 3,16x
Capitalization 186 B
Duration : Period :
Procter & Gamble Company Technical Analysis Chart | PG | US7427181091 | 4-Traders
Technical analysis trends PROCTER & GAMBLE COMPANY
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus HOLD
Number of Analysts 23
Average target price 81,6 $
Spread / Average Target 12%
EPS Revisions
David S. Taylor Chairman, President & Chief Executive Officer
Jon R. Moeller Vice Chairman & Chief Financial Officer
Kathleen B. Fish Chief Technology Officer
Terrence J. Porter Vice President-Global Research & Development
Javier Polit Chief Information Officer
Sector and Competitors
1st jan.Capitalization (M$)
UNILEVER NV (ADR)-2.36%162 999
UNILEVER (NL)-3.62%162 239
UNILEVER-6.29%162 239